Meeting Report
Racial Disparities, Advanced Ovarian Cancer, and HER2 Expression: 2023 ASCO Annual Meeting Highlights for the Advanced Practitioner
Andrew S. Guinigundo, MSN, RN, CNP, ANP-BC
J Adv Pract Oncol 2023;14(6):6-13 |
https://doi.org/10.6004/jadpro.2023.14.6.9 |
© 2023 BroadcastMed LLC
ABSTRACT
Andrew S. Guinigundo, MSN, RN, CNP, ANP-BC, of Cincinnati Cancer Advisors, discusses the effect of Medicaid expansion on racial disparities in mortality among patients with gastrointestinal malignancies. He also describes the phase III DUO-O trial, which evaluated therapies for patients with advanced ovarian cancer without a BRCA1/2 mutation. Finally, the first tumor-agnostic global study of fam-trastuzumab deruxtecan-nxki showed encouraging results in patients with different cancers.
For access to the full length article, please
sign in.
